News
Hosted on MSN3mon
A new strategy to enhance gene therapy for sickle cell disease
Anne Galy, Ph.D., from Inserm, and co-authors, applied a novel lentivirus-based gene therapy strategy in CD34 + hematopoietic progenitor and stem cells (HSPCs) obtained from cord blood.
Caption Extracellular vesicles are tiny spheres that cells release to send molecules or messages to other cells, often as a means of seeding cancer elsewhere in the body. In a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results